malondialdehyde has been researched along with Bronchopulmonary Dysplasia in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
Authors | Studies |
---|---|
Gan, C; Jin, Z; Wang, X; Wu, J; Yang, X; Yao, S; Yu, W; Zhang, L | 1 |
Aslan, M; Gokce, IK; Gul, CC; Kaya, H; Ozdemir, R; Sandal, S; Tanbek, K; Taslidere, AC; Turgut, H | 1 |
Aydemir, S; Çakır, E; Çakır, U; Çifci, A; Halil, H; Tayman, C; Yakut, Hİ | 1 |
Deng, L; Huang, WM; Jia, HL; Wang, XH | 1 |
Bi, Y; Huang, B; Li, Q; Tian, M; Xu, F; Xu, S; Zhen, X | 1 |
Alyamac Dizdar, E; Canpolat, FE; Dilmen, U; Gokce, IK; Gonul, II; Oncel, MY; Topal, T; Yurttutan, S | 1 |
Barrios, R; Reynolds, CL; Shivanna, B; Shrestha, AK; Zhang, S | 1 |
Antunes, LC; Kurokawa, CS; Lyra, JC; Madoglio, RJ; Rugolo, LM; Sá, MP | 1 |
Collard, KJ; Godeck, S; Holley, JE; Quinn, MW | 1 |
Collard, KJ; Godeck, S; Holley, JE | 1 |
Chen, N; Li, JJ; Xue, XD | 1 |
Bhogal, M; Hart, D; McCarthy, K; Nardi, M | 1 |
Bervoets, K; Böhles, H; Schlenzig, JS; von Loewenich, V | 1 |
Buss, IH; Darlow, BA; Winterbourn, CC | 1 |
1 trial(s) available for malondialdehyde and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants.
Topics: Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Female; Gestational Age; Humans; Hyaline Membrane Disease; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Very Low Birth Weight; Lipid Peroxidation; Malondialdehyde; Neutrophils; Obstetric Labor, Premature; Peroxidase; Pregnancy; Trachea | 2000 |
13 other study(ies) available for malondialdehyde and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Nesfatin-1 alleviates hyperoxia-induced lung injury in newborn mice by inhibiting oxidative stress through regulating SIRT1/PGC-1α pathway.
Topics: Alveolar Epithelial Cells; Animals; bcl-2-Associated X Protein; Bronchopulmonary Dysplasia; Female; Hyperoxia; Male; Malondialdehyde; Mice; Nucleobindins; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sirtuin 1; Superoxide Dismutase | 2023 |
Does Chrysin prevent severe lung damage in Hyperoxia-Induced lung injury Model?
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Bronchopulmonary Dysplasia; Caspase 3; Disease Models, Animal; Flavonoids; Glutathione Peroxidase; Glutathione Reductase; Hyperoxia; Interleukin-1beta; Lung Injury; Macrophages, Alveolar; Malondialdehyde; Oxidants; Oxidative Stress; Oxygen; Rats, Wistar; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2021 |
Ginger (\
Zingiber\
officinale\
) prevents severe damage to the lungs due to hyperoxia and \
inflammation
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Bronchopulmonary Dysplasia; Chorioamnionitis; Disease Models, Animal; Female; Humans; Hyperoxia; Infant, Newborn; Infant, Premature; Inflammation; Inflammation Mediators; Lung; Lung Diseases; Malondialdehyde; Oxidative Stress; Oxygen; Phytotherapy; Plant Extracts; Pregnancy; Rats, Wistar; Zingiber officinale | 2018 |
Astragalus polysaccharides mediated preventive effects on bronchopulmonary dysplasia in rats.
Topics: Animals; Animals, Newborn; Astragalus Plant; Blotting, Western; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Intercellular Adhesion Molecule-1; Lung; Malondialdehyde; Polysaccharides; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2014 |
Substance P protects against hyperoxic-induced lung injury in neonatal rats.
Topics: Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Drug Evaluation, Preclinical; Edema; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Glutathione Peroxidase; Hyperoxia; Lung; Malondialdehyde; Neurotransmitter Agents; NF-E2-Related Factor 2; Pregnancy; Random Allocation; Rats, Sprague-Dawley; Substance P; Superoxide Dismutase | 2015 |
Beneficial Effect of Etanercept on Hyperoxic Lung Injury Model in Neonatal Rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchopulmonary Dysplasia; Disease Models, Animal; Etanercept; Female; Humans; Hyperoxia; Infant, Newborn; Infant, Premature; Lung; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2016 |
Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
Topics: Actins; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Disease Models, Animal; Disease Progression; Echocardiography, Doppler, Pulsed; Feasibility Studies; Female; Hemodynamics; Hyperoxia; Hypertension, Pulmonary; Lung; Male; Malondialdehyde; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Oxidative Stress; Predictive Value of Tests; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Time Factors; Vascular Remodeling; von Willebrand Factor | 2016 |
Inflammatory and oxidative stress airway markers in premature newborns of hypertensive mothers.
Topics: Biomarkers; Bronchopulmonary Dysplasia; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Infant, Premature; Inflammation; Interleukin-8; Longitudinal Studies; Malondialdehyde; Nitric Oxide; Oxidative Stress; Predictive Value of Tests; Prospective Studies | 2016 |
Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies.
Topics: Aging; Antioxidants; Ascorbic Acid; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Cohort Studies; Glutathione; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infections; Lipid Peroxidation; Logistic Models; Lung; Malondialdehyde; Oxidative Stress; Oxygen; Prognosis; Respiration, Artificial; Uric Acid | 2004 |
Blood transfusion and pulmonary lipid peroxidation in ventilated premature babies.
Topics: Biomarkers; Blood Transfusion; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipid Peroxidation; Lung; Malondialdehyde; Outcome and Process Assessment, Health Care; Respiration, Artificial; Retrospective Studies | 2005 |
[Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Humans; Hydroxyproline; Hyperoxia; Infant, Newborn; Losartan; Lung; Malondialdehyde; Pulmonary Fibrosis; Rats; Rats, Wistar; Superoxide Dismutase | 2007 |
Pathogenic factors in bronchopulmonary dysplasia.
Topics: alpha 1-Antitrypsin; Blood Proteins; Bronchopulmonary Dysplasia; Ceruloplasmin; Female; Gestational Age; Humans; Infant, Newborn; Male; Malondialdehyde; Respiration, Artificial; Vitamin E | 1984 |
Urinary malondialdehyde concentration in preterm neonates: is there a relationship to disease entities of neonatal intensive care?
Topics: Birth Weight; Bronchopulmonary Dysplasia; Free Radicals; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care, Neonatal; Malondialdehyde; Oxygen; Respiration, Artificial; Retrospective Studies | 1993 |